Janux Therapeutics, Inc. - Common Stock (JANX)

Historical Holders from Q2 2021 to Q3 2025

Symbol
JANX on Nasdaq
CUSIP
47103J105
Type / Class
Equity / Common Stock
Shares outstanding
60.3M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
65M
Holdings value
$1.59B
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
163
Number of buys
77
Number of sells
-82
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Janux Therapeutics, Inc. - Common Stock (JANX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 19.9% $321M 12M RA Capital Management, L.P. Mar 6, 2025
JANUS HENDERSON GROUP PLC 10% +31.3% $147M $38.5M 6.03M +35.3% JANUS HENDERSON GROUP PLC Oct 31, 2025
BlackRock, Inc. 5.7% $85.5M 3.35M BlackRock, Inc. Jun 30, 2025
Paradigm Biocapital Advisors LP 4.9% -18.3% $67.3M -$13.7M 2.92M -16.9% Paradigm BioCapital Advisors LP Jun 30, 2025
Adage Capital Management, L.P. 4.27% -20.8% $58.3M -$12.4M 2.53M -17.5% Adage Capital Management, L.P. Jun 30, 2025

Institutional Holders of Janux Therapeutics, Inc. - Common Stock (JANX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 65M $1.59B -$4.06M $24.44 163
2025 Q2 65.4M $1.51B -$28.1M $23.10 170
2025 Q1 66.5M $1.81B -$17.6M $27.00 179
2024 Q4 64.1M $3.43B +$1B $53.54 212
2024 Q3 45.6M $2.07B +$42.3M $45.43 159
2024 Q2 44.7M $1.87B +$108M $41.89 152
2024 Q1 42.3M $1.59B +$332M $37.65 118
2023 Q4 33.5M $360M -$17.7M $10.73 64
2023 Q3 35.1M $354M +$43.9M $10.08 57
2023 Q2 30.5M $362M -$1.13M $11.87 54
2023 Q1 30.5M $370M +$18.6M $12.10 48
2022 Q4 29M $381M -$7.76M $13.17 48
2022 Q3 29.5M $400M +$8.92M $13.54 44
2022 Q2 28.9M $352M +$6.49M $12.21 39
2022 Q1 28.3M $407M +$10.9M $14.34 45
2021 Q4 27.5M $541M +$19.1M $19.73 45
2021 Q3 26.5M $571M +$36.9M $21.63 45
2021 Q2 24.7M $614M +$614M $24.95 29